{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:38Z","timestamp":1787841338592,"version":"build-2784847793"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lymphoblastic lymphomas (LBLs) are neoplasms of precursor B and T cells; they are considered in the same spectrum as precursor B and T cell acute lymphoblastic leukemia (ALL). The World Health Organization classification classifies both LBL and ALL as one disease entity. While chromosome abnormalities are well defined with all of their therapeutic and prognostic implications in ALL, these are not well studied in LBL. Here, we describe a case of Philadelphia chromosomepositive LBL and review the available literature regarding this entity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T05:10:25Z","timestamp":1529039425000},"page":"242-243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or underdiagnosed?"],"prefix":"10.4103","volume":"13","author":[{"given":"Ahmad","family":"Alshomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad El","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20241211","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s002770100363","article-title":"Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients","volume":"80","author":"Chen","year":"2001","journal-title":"Ann Hematol"},{"key":"R2-9-20241211","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"R3-9-20241211","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ajcp\/112.6.836","article-title":"Precursor B lymphoblastic lymphoma presenting as lytic bone lesions","volume":"112","author":"Iravani","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R4-9-20241211","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1182\/blood-2008-04-149286","article-title":"Patients\u2019 age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group","volume":"112","author":"Burmeister","year":"2008","journal-title":"Blood"},{"key":"R5-9-20241211","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood-2009-01-199380","article-title":"Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII\/ ECOG2993","volume":"113","author":"Fielding","year":"2009","journal-title":"Blood"},{"key":"R6-9-20241211","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3109\/10428194.2012.760735","article-title":"Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone","volume":"54","author":"Sadrzadeh","year":"2013","journal-title":"Leukemia Lymphoma"},{"key":"R7-9-20241211","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1080\/15384047.2015.1056412","article-title":"Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review","volume":"16","author":"Zhu","year":"2015","journal-title":"Cancer Biol Ther"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387618300633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387618300633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2018.05.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:50:10Z","timestamp":1787838610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2018.05.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2018.05.007","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}